TEX261 Inhibitors
Chemical inhibitors of TEX261 operate through various mechanisms to impede its function within cellular pathways. Staurosporine, a broad-spectrum protein kinase inhibitor, can inhibit TEX261 by hampering the activity of kinases essential for its phosphorylation, thereby directly reducing its activity. Bisindolylmaleimide I targets protein kinase C (PKC), and by inhibiting PKC, it can reduce the phosphorylation state of TEX261, assuming PKC or PKC-regulated pathways modulate TEX261. Wortmannin and LY294002, both phosphoinositide 3-kinases (PI3K) inhibitors, can prevent PI3K-dependent processes vital for TEX261's function. This action results in the direct inhibition of TEX261 by obstructing the signaling pathways that might be crucial for its activation or localization.
Furthermore, Rapamycin acts upon the mammalian target of rapamycin (mTOR) pathway. If TEX261's activity is contingent on mTOR-mediated signaling, its inhibition by rapamycin would lead to a decrease in TEX261 function. PD98059 and U0126, both MEK inhibitors, can inhibit TEX261 by blocking the MAPK/ERK pathway, assuming the pathway is necessary for TEX261's regulatory mechanisms or activity. Similarly, SP600125 and SB203580, which target c-Jun N-terminal kinase (JNK) and p38 MAP kinase respectively, can diminish TEX261's activity by inhibiting these kinase-mediated regulatory pathways. Lastly, proteasome inhibitors like Bortezomib, MG132, and Lactacystin can inhibit TEX261 by preventing the proteasomal degradation of either TEX261 itself or proteins that regulate its function, leading to an accumulation of inhibitors or the stabilization of TEX261 in an inactive state.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
As a potent inhibitor of protein kinases, Staurosporine can inhibit TEX261 by obstructing the protein kinases that are crucial for TEX261’s function or activation, thus directly reducing its activity by preventing phosphorylation events required for TEX261 activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
This compound is a specific inhibitor of protein kinase C (PKC), and by inhibiting PKC, it could reduce the phosphorylation of TEX261 assuming TEX261 is a substrate for PKC or is regulated by PKC-dependent pathways, resulting in functional inhibition of TEX261. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin inhibits phosphoinositide 3-kinases (PI3K), and if TEX261’s activity is PI3K-dependent, this would lead to an inhibition of TEX261 by preventing PI3K-mediated signaling pathways that might control the function or localization of TEX261. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Similar to Wortmannin, LY294002 is also a PI3K inhibitor. By inhibiting PI3K, it can prevent any PI3K-dependent processes that are necessary for TEX261 function, leading to a direct inhibition of TEX261. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits the mammalian target of rapamycin (mTOR), and if TEX261 activity is mTOR-dependent, this inhibition can prevent TEX261 functioning by blocking mTOR signaling pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is a MEK inhibitor, which may inhibit TEX261 by blocking the MAPK/ERK pathway, assuming that TEX261 is regulated by this pathway or interacts with proteins in this pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
This inhibitor targets c-Jun N-terminal kinase (JNK), and if JNK signaling regulates TEX261, SP600125 can inhibit TEX261 by preventing JNK-mediated phosphorylation or regulation of TEX261. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 inhibits p38 MAP kinase. If TEX261 is regulated by p38 MAPK signaling, inhibition of this kinase would result in inhibition of TEX261 activity by preventing necessary phosphorylation or protein-protein interactions. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 is another MEK inhibitor, and by inhibiting MEK, it can inhibit TEX261 by blocking the MAPK/ERK pathway, assuming TEX261 requires this pathway for its function or is regulated by components of this pathway. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib is a proteasome inhibitor, which can inhibit TEX261 by preventing the degradation of regulatory proteins that are essential for TEX261 function, potentially leading to an accumulation of suppressors of TEX261 activity. | ||||||